Literature DB >> 23152533

Multiple Gag domains contribute to selective recruitment of murine leukemia virus (MLV) Env to MLV virions.

Devon A Gregory1, Terri D Lyddon, Marc C Johnson.   

Abstract

Retroviruses, like all enveloped viruses, must incorporate viral glycoproteins to form infectious particles. Interactions between the glycoprotein cytoplasmic tail and the matrix domain of Gag are thought to direct recruitment of glycoproteins to native virions for many retroviruses. However, retroviruses can also incorporate glycoproteins from other viruses to form infectious virions known as pseudotyped particles. The glycoprotein murine leukemia virus (MLV) Env can readily form pseudotyped particles with many retroviruses, suggesting a generic mechanism for recruitment. Here, we sought to identify which components of Gag, particularly the matrix domain, contribute to recruitment of MLV Env into retroviral particles. Unexpectedly, we discovered that the matrix domain of HIV-1 Gag is dispensable for generic recruitment, since it could be replaced with a nonviral membrane-binding domain without blocking active incorporation of MLV Env into HIV virions. However, MLV Env preferentially assembles with MLV virions. When MLV and HIV particles are produced from the same cell, MLV Env is packaged almost exclusively by MLV particles, thus preventing incorporation into HIV particles. Surprisingly, the matrix domain of MLV Gag is not required for this selectivity, since MLV Gag containing the matrix domain from HIV is still able to outcompete HIV particles for MLV Env. Although MLV Gag is sufficient for selective incorporation to occur, no single Gag domain dictates the selectivity. Our findings indicate that Env recruitment is more complex than previously believed and that Gag assembly/budding sites have fundamental properties that affect glycoprotein incorporation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23152533      PMCID: PMC3554149          DOI: 10.1128/JVI.02604-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.

Authors:  M A Accola; B Strack; H G Göttlinger
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 2.  The pseudotypic paradox.

Authors:  J Závada
Journal:  J Gen Virol       Date:  1982-11       Impact factor: 3.891

3.  Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide.

Authors:  N Green; T M Shinnick; O Witte; A Ponticelli; J G Sutcliffe; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

4.  Characterization of the murine leukemia virus protease and its comparison with the human immunodeficiency virus type 1 protease.

Authors:  Anita Fehér; Péter Boross; Tamás Sperka; Gabriella Miklóssy; János Kádas; Péter Bagossi; Stephen Oroszlan; Irene T Weber; József Tözsér
Journal:  J Gen Virol       Date:  2006-05       Impact factor: 3.891

5.  Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail.

Authors:  T Murakami; E O Freed
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  Mutations altering the moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle.

Authors:  B Yuan; X Li; S P Goff
Journal:  EMBO J       Date:  1999-09-01       Impact factor: 11.598

7.  Direct interaction between the envelope and matrix proteins of HIV-1.

Authors:  P Cosson
Journal:  EMBO J       Date:  1996-11-01       Impact factor: 11.598

8.  Positive and negative modulation of virus infectivity and envelope glycoprotein incorporation into virions by amino acid substitutions at the N terminus of the simian immunodeficiency virus matrix protein.

Authors:  Julieta M Manrique; Cristina C P Celma; Eric Hunter; José L Affranchino; Silvia A González
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms.

Authors:  M Yeager; E M Wilson-Kubalek; S G Weiner; P O Brown; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

10.  Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein.

Authors:  A Rein; J Mirro; J G Haynes; S M Ernst; K Nagashima
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more
  8 in total

1.  Retrovirus glycoprotein functionality requires proper alignment of the ectodomain and the membrane-proximal cytoplasmic tail.

Authors:  Sanath Kumar Janaka; Devon A Gregory; Marc C Johnson
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

2.  Sequence Determinants in Gammaretroviral Env Cytoplasmic Tails Dictate Virus-Specific Pseudotyping Compatibility.

Authors:  Yul Eum Song; Grace Y Olinger; Sanath Kumar Janaka; Marc C Johnson
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

3.  In Vivo Analysis of Infectivity, Fusogenicity, and Incorporation of a Mutagenic Viral Glycoprotein Library Reveals Determinants for Virus Incorporation.

Authors:  Daniel J Salamango; Khalid K Alam; Donald H Burke; Marc C Johnson
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

4.  Intact Viral Particle Counts Measured by Flow Virometry Provide Insight into the Infectivity and Genome Packaging Efficiency of Moloney Murine Leukemia Virus.

Authors:  Tyler Milston Renner; Vera A Tang; Dylan Burger; Marc-André Langlois
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

Review 5.  The cytoplasmic tail of retroviral envelope glycoproteins.

Authors:  Philip R Tedbury; Eric O Freed
Journal:  Prog Mol Biol Transl Sci       Date:  2014-12-01       Impact factor: 3.622

Review 6.  The role of matrix in HIV-1 envelope glycoprotein incorporation.

Authors:  Philip R Tedbury; Eric O Freed
Journal:  Trends Microbiol       Date:  2014-06-02       Impact factor: 17.079

7.  Basic residues in the matrix domain and multimerization target murine leukemia virus Gag to the virological synapse.

Authors:  Fei Li; Jing Jin; Christin Herrmann; Walther Mothes
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

8.  Diverse viral glycoproteins as well as CD4 co-package into the same human immunodeficiency virus (HIV-1) particles.

Authors:  Devon A Gregory; Grace Y Olinger; Tiffany M Lucas; Marc C Johnson
Journal:  Retrovirology       Date:  2014-04-03       Impact factor: 4.602

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.